Penner C G, Murphy L C, Huzel N J, Yamada E W
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.
Mol Cell Biochem. 1991 Nov 13;108(1):57-66. doi: 10.1007/BF00239542.
Phosphorylation of ribosomal protein S6 of mammals precedes activation of cell growth in numerous biological systems. We have cloned a cDNA for ribosomal protein S6 from T-47D human breast cancer cells by immunoscreening a lambda gt11 expression library with antibody raised against the mitochondrial Ca(2+)-binding ATPase inhibitor protein (CaBI) of bovine heart mitochondria (Yamada & Huzel: J Biol Chem 263: 11498-11503, 1988). Similar clones were obtained by the immunoscreening of a rat heart expression library. In agreement with others, the open reading frames of the cDNAs from the two species coded for the same amino acid sequence. No difference in S6 of the human neoplastic cells compared to that of non-neoplastic cells was found. However, common antigenic determinants in S6 and CaBI were indicated. Accordingly, S6 was purified from rat liver ribosomes and antiserum prepared. Immuno-dot blot and Western blot analyses showed high specific reactivity between S6, the cloned chimeric beta-galactosidase fusion protein from a cDNA clone, and CaBI with anti-S6 and anti-CaBI antibodies. The antibodies also showed a high degree of discrimination for S6 and CaBI. Neither interacted with the other ribosomal proteins nor with another ATPase inhibitor protein from bovine heart mitochondria. Neither interacted with the Ca(2+)-binding proteins, calmodulin, oncomodulin, Protein C, or Factor X. Prothrombin was weakly reactive with anti-CaBI but not with anti-S6. Thus, the results fulfill the specific criteria for the concept and operational definition of common protein epitopes in S6 and CaBI. However, neither prothrombin nor S6 fusion protein inhibited mitochondrial ATPase activity even at 20 times the concentrations at which CaBI gave 97% inhibition.
在众多生物系统中,哺乳动物核糖体蛋白S6的磷酸化先于细胞生长的激活。我们通过用针对牛心线粒体的线粒体Ca(2+)结合ATP酶抑制剂蛋白(CaBI)产生的抗体免疫筛选λgt11表达文库,从T-47D人乳腺癌细胞中克隆了核糖体蛋白S6的cDNA(山田和胡泽尔:《生物化学杂志》263: 11498 - 11503,1988)。通过对大鼠心脏表达文库的免疫筛选获得了类似的克隆。与其他人的研究一致,这两个物种cDNA的开放阅读框编码相同的氨基酸序列。未发现人类肿瘤细胞的S6与非肿瘤细胞的S6有差异。然而,表明S6和CaBI中有共同的抗原决定簇。因此,从大鼠肝脏核糖体中纯化出S6并制备了抗血清。免疫斑点印迹和蛋白质印迹分析显示,S6、来自cDNA克隆的克隆嵌合β-半乳糖苷酶融合蛋白以及CaBI与抗S6和抗CaBI抗体之间具有高特异性反应性。这些抗体对S6和CaBI也表现出高度的区分性。它们既不与其他核糖体蛋白相互作用,也不与来自牛心线粒体的另一种ATP酶抑制剂蛋白相互作用。它们既不与Ca(2+)结合蛋白、钙调蛋白、癌调蛋白、蛋白C或因子X相互作用。凝血酶原与抗CaBI有弱反应,但与抗S6无反应。因此,这些结果符合S6和CaBI中共同蛋白质表位概念和操作定义的具体标准。然而,即使在CaBI产生97%抑制作用的浓度的20倍时,凝血酶原和S6融合蛋白也不抑制线粒体ATP酶活性。